Publications in collaboration with researchers from Hospital Universitario de Salamanca (18)

2024

  1. Cáncer epitelial de ovario. Cáncer de cérvix. Cáncer de endometrio

    Oncología clínica (Arán), pp. 319-336

  2. Epidemiología del cáncer. Factores de riesgo y carcinogénesis

    Oncología clínica (Arán), pp. 25-42

  3. Prevención del cáncer. Consejo genético y cáncer hereditario

    Oncología clínica (Arán), pp. 43-58

  4. Real-world dosing patterns of regorafenib for patients with metastatic colorectal cancer in Spain: the RE-SEARCH study

    Clinical and Translational Oncology

2023

  1. Real-world safety and effectiveness of maintenance niraparib for platinum-sensitive recurrent ovarian cancer: A GEICO retrospective observational study within the Spanish expanded-access programme

    European Journal of Cancer, Vol. 182, pp. 3-14

2022

  1. Immunohistochemical Assessment of the P53 Protein as a Predictor of Non-Small Cell Lung Cancer Response to Immunotherapy

    Frontiers in bioscience (Landmark edition), Vol. 27, Núm. 3, pp. 88

  2. Influence of DNA Mismatch Repair (MMR) System in Survival and Response to Immune Checkpoint Inhibitors (ICIs) in Non-Small Cell Lung Cancer (NSCLC): Retrospective Analysis

    Biomedicines, Vol. 10, Núm. 2

2020

  1. Quality of life of patients with metastatic pancreatic adenocarcinoma initiating first-line chemotherapy in routine practice

    BMC Palliative Care, Vol. 19, Núm. 1

  2. SEOM clinical guideline on hereditary colorectal cancer (2019)

    Clinical and Translational Oncology, Vol. 22, Núm. 2, pp. 201-212

2017

  1. Spontaneous nasal perforation in a bevacizumab-treated patient with metastatic breast cancer

    Breast Journal, Vol. 23, Núm. 6, pp. 745-746

2015

  1. Clinical guideline seom: hereditary colorectal cancer

    Clinical and Translational Oncology, Vol. 17, Núm. 12, pp. 962-971

2012

  1. Shorter telomere length is associated with increased: Ovarian cancer risk in both familial and sporadic cases

    Journal of Medical Genetics, Vol. 49, Núm. 5, pp. 341-344

2011

  1. Pacientes con criterios clínicos de síndrome de Lynch con y sin mutación en genes reparadores del ADN (MLH1 y MSH2). Un reto para el clínico

    Medicina Clinica, Vol. 137, Núm. 4, pp. 166-170

2006

  1. Helminth-related eosinophilia in African immigrants, Gran Canaria

    Emerging Infectious Diseases, Vol. 12, Núm. 10, pp. 1587-1589

2005

  1. Biweekly docetaxel and vinorelbine with granulocyte colony-stimulating factor support for patients with anthracycline-resistant metastatic breast cancer

    Anti-Cancer Drugs, Vol. 16, Núm. 1, pp. 77-82

2002

  1. Serum CYFRA 21-1 is one of the most reliable tumor markers for breast carcinoma [1] (multiple letters)

    Cancer

1997

  1. Comparison and variation of different methodologies for the detection of autoantibodies to nuclear antigens (ANA)

    Journal of Clinical Laboratory Analysis, Vol. 11, Núm. 6, pp. 388-392

1996

  1. Hydrolytic enzyme of the alveolar macrophage in diffuse pulmonary interstitial disease

    Respiratory Medicine, Vol. 90, Núm. 3, pp. 159-166